Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium

被引：0
|
作者：
Wong, JB [1 ]
Nevens, F [1 ]
机构：
[1] Tufts Univ, Sch Med, New England Med Ctr, Tupper Res Inst,Dept Med,Div Clin Decis Making, Boston, MA 02111 USA
来源：
ACTA GASTRO-ENTEROLOGICA BELGICA | 2002年 / 65卷 / 02期
关键词：
hepatitis C; cost-effectiveness analysis; interferon; ribavirin;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [1] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    [J]. LANCET, 2001, 358 (9286): : 958 - 965
  • [2] Peginterferon alfa-2b plus ribavirin for chronic hepatitis
    Cecil, BD
    [J]. LANCET, 2002, 359 (9302): : 263 - 264
  • [3] Peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M
    Sauleda, S
    Esteban, JI
    Juarez, A
    Buti, M
    Pahissa, A
    Esteban, R
    Guardia, J
    [J]. HEPATOLOGY, 2005, 42 (04) : 701A - 702A
  • [4] Cost-effectiveness of initial ribavirin interferon alfa-2B for chronic hepatitis C
    Wong, J
    McHutchinson, JG
    Poynard, T
    Ling, MH
    Albrecht, HK
    Pauker, SD
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A1289 - A1289
  • [5] The cost-effectiveness of peginterferon alfa-2b (12KD) plus ribavirin vs. interferon alfa-2b plus ribavirin for chronic hepatitis C (CHC) in a developing country - Brazil
    Fonseca, MC
    Araujo, GTB
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A119 - A120
  • [6] Cost-utility-analysis of peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin as initial therapy for Chinese naive patients with chronic hepatitis C
    Tarn, YH
    Lin, WA
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A46 - A46
  • [7] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients
    Laguno, M
    Murillas, J
    Blanco, JL
    Martínez, E
    Miquel, R
    Sánchez-Tapias, JM
    Bargallo, X
    García-Criado, A
    de Lazzari, E
    Larrousse, M
    León, A
    Loncá, M
    Milinkovic, A
    Gatell, JM
    Mallolas, J
    [J]. AIDS, 2004, 18 (13) : F27 - F36
  • [8] Peginterferon alfa-2b plus ribavirin for retreatment of chronic hepatitis C
    Dalke, DD
    Donovan, J
    Mailliard, M
    Monsour, H
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A667 - A667
  • [9] Peginterferon alfa-2b plus ribavirin for chronic hepatitis - Reply
    Manns, MP
    McHutchison, J
    Koury, K
    Albrecht, JK
    [J]. LANCET, 2002, 359 (9302): : 264 - 264
  • [10] A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C
    Buti, M
    Medina, M
    Casado, MA
    Wong, JB
    Fosbrook, L
    Esteban, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (05) : 687 - 694
12345